NTRBW

Nutriband Inc. Warrant
NASDAQ

Key Statistics

Market Cap
P/E Ratio
EPS
$-0.51
Beta
1.94
52W High
$2.99
52W Low
$0.50
50-Day MA
$0.92
200-Day MA
$1.39
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About Nutriband Inc. Warrant

Nutraband Inc. Warrant (NTRBW) provides an exceptional investment vehicle linked to Nutriband Inc., an innovative biotechnology firm dedicated to developing advanced transdermal drug delivery systems that address critical healthcare challenges, particularly in pain management and addiction treatment. The company is distinguished by its proprietary technologies and a strong product pipeline poised for substantial market impact. With a strategic focus on leveraging growth opportunities within the pharmaceutical sector, Nutriband presents an appealing proposition for institutional investors seeking to capitalize on advancements in biotechnology and healthcare innovation.

Official WebsiteUSAFY End: January

Fundamentals

Revenue (TTM)$1.80M
Gross Profit (TTM)511,130
EBITDA$-7.99M
Operating Margin-289.40%
Return on Equity-145.70%
Return on Assets-78.20%
Revenue/Share (TTM)$0.15
Book Value$0.49
Price-to-Book
Price-to-Sales (TTM)
EV/Revenue-
EV/EBITDA
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-35.10%
Shares Outstanding0
Float$5.28M
% Insiders0.00%
% Institutions0.00%

Historical Volatility

HV 10-Day
81.68%
HV 20-Day
157.08%
HV 30-Day
180.26%
HV 60-Day
161.28%
HV Rank

Volatility is currently contracting

Latest News

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Nutriband's Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference Company to Meet with Buyers from Walmart Inc, Walgreens, Amazon.com, Inc., Cardinal Health and Other Major National Retailers ORLANDO, Fla., May 15, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) and its wholly owned subsidiary Active Intelligence (“Active Intelligence” or the “Company”), an emerging leader in innovative wellness, recovery, and performance-focused consumer products, today announced its participation in the upcoming ECRM conference taking place in June 2026, where the Company will showcase its latest AI-branded product portfolio to buyers and executives from some of the nation's largest retail and healthcare organizations.

GlobeNewsWire5/15/2026Neutral
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

ORLANDO, Fla., April 22, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan has featured on the latest episode of the Jack Neel Podcast to discuss the opioid crisis, the Company's AVERSA technology and the opportunity for Nutriband to improve the safety profile of easily abused medications.

GlobeNewsWire4/22/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NTRBW and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works
Data last updated: 7/29/2026